Ultrathin bioresorbable polymer sirolimus-eluting stents in US patients undergoing coronary revascularization: 1-Year outcomes from the BIOFLOW VII trial.
David E KandzariHector M Garcia-GarciaRobert C StolerJohn WangMark PiconeItsik Ben-DorSantiago A GarciaPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2023)
In a post-approval study, 1-year clinical outcomes with BP SES were consistent with prior trials supporting the safety and effectiveness of ultrathin BP SES.
Keyphrases
- patients undergoing
- randomized controlled trial
- coronary artery disease
- high efficiency
- systematic review
- study protocol
- clinical trial
- percutaneous coronary intervention
- phase iii
- coronary artery bypass grafting
- phase ii
- metal organic framework
- acute coronary syndrome
- aortic stenosis
- left ventricular
- ejection fraction
- double blind